Daewoong Co., Ltd. (KRX:003090)
21,150
+200 (0.95%)
Feb 21, 2025, 9:00 AM KST
Daewoong Revenue
Daewoong had revenue of 515.87B KRW in the quarter ending September 30, 2024, with 11.78% growth. This brings the company's revenue in the last twelve months to 1.88T, up 3.77% year-over-year. In the year 2023, Daewoong had annual revenue of 1.81T with 6.86% growth.
Revenue (ttm)
1,880.07B
Revenue Growth
+3.77%
P/S Ratio
0.46
Revenue / Employee
5.28B
Employees
356
Market Cap
864.84B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,813.84B | 116.50B | 6.86% |
Dec 31, 2022 | 1,697.34B | 185.96B | 12.30% |
Dec 31, 2021 | 1,511.37B | 156.04B | 11.51% |
Dec 31, 2020 | 1,355.34B | -10.34B | -0.76% |
Dec 31, 2019 | 1,365.68B | 134.39B | 10.91% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanmi Science | 1,283.65B |
Hanall Biopharma | 134.24B |